Literature DB >> 33349022

Advances in Stroke: Therapies Targeting Stroke Recovery.

Lorie G Richards1, Steven C Cramer2.   

Abstract

Stroke recovery therapies promote favorable neural plasticity, both during spontaneous recovery and the chronic phase. Activity-based therapies based on intense practice, some aided by integration of computers and telehealth, have shown promise. These studies emphasize key therapeutic variables such as dose, intensity, and timing. Preclinical drug studies have shown promise, but human translation has been challenged by identifying the target patient subgroup, requirements for concomitant training, and aligning biomarkers with preclinical evidence.

Entities:  

Keywords:  arm; biomarkers; brain; gait; telerehabilitation

Mesh:

Year:  2020        PMID: 33349022     DOI: 10.1161/STROKEAHA.120.033231

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

Review 1.  Neural Stem Cells Therapy for Ischemic Stroke: Progress and Challenges.

Authors:  Tong Zhao; Tongming Zhu; Liqian Xie; Yao Li; Rong Xie; Feng Xu; Hailiang Tang; Jianhong Zhu
Journal:  Transl Stroke Res       Date:  2022-01-15       Impact factor: 6.800

2.  Using Robot-Based Variables during Upper Limb Robot-Assisted Training in Subacute Stroke Patients to Quantify Treatment Dose.

Authors:  Pascal Jamin; Christophe Duret; Emilie Hutin; Nicolas Bayle; Typhaine Koeppel; Jean-Michel Gracies; Ophélie Pila
Journal:  Sensors (Basel)       Date:  2022-04-13       Impact factor: 3.847

3.  Altered effective connectivity in the emotional network induced by immersive virtual reality rehabilitation for post-stroke depression.

Authors:  Jia-Jia Wu; Mou-Xiong Zheng; Xu-Yun Hua; Dong Wei; Xin Xue; Yu-Lin Li; Xiang-Xin Xing; Jie Ma; Chun-Lei Shan; Jian-Guang Xu
Journal:  Front Hum Neurosci       Date:  2022-08-02       Impact factor: 3.473

4.  Editorial: Long term disability in neurological disease: A rehabilitation perspective.

Authors:  Alessio Baricich; Grazia F Spitoni; Giovanni Morone
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.